Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay

被引：25

作者：

Abenavoli, Ludovico ^{[1
]}

Giubilei, Lidia ^{[1
]}

Procopio, Anna Caterina ^{[1
]}

Spagnuolo, Rocco ^{[1
]}

Luzza, Francesco ^{[1
]}

Boccuto, Luigi ^{[2
]}

Scarpellini, Emidio ^{[3
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy

[2] Clemson Univ, Sch Nursing, Clemson, SC 29634 USA

[3] Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders TARGID, Gasthuisberg Univ Hosp, Herestr 49, B-3000 Leuven, Belgium

来源：

NUTRIENTS | 2022年 / 14卷 / 24期

关键词：

microbiota; non-alcoholic fatty liver disease; Crohn's disease; ulcerative colitis; EXPRESSION; ABUNDANCE; DYSBIOSIS;

D O I：

10.3390/nu14245323

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

The intestinal microbiota represents the microbial community that colonizes the gastrointestinal tract and constitutes the most complex ecosystem present in nature. The main intestinal microbial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucromicrobia, with a clear predominance of the two phyla Firmicutes and Bacteroidetes which account for about 90% of the intestinal phyla. Intestinal microbiota alteration, or dysbiosis, has been proven to be involved in the development of various syndromes, such as non-alcoholic fatty liver disease, Crohn's disease, and ulcerative colitis. The present review underlines the most recurrent changes in the intestinal microbiota of patients with NAFLD, Crohn's disease, and ulcerative colitis.

引用

页数：10

共 50 条

[31] Increased Risk of Non-Alcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease
Inamdar, Sumant
Sultan, Keith
Bernstein, David
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S666 - S667
[32] Non-Alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Bosch, Dustin
Boukhar, Sarag
Koch, Lisa
Jalikis, Florencia
Yeh, Matthew M.
LABORATORY INVESTIGATION, 2017, 97 : 414A - 414A
[33] Non-Alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Bosch, Dustin
Boukhar, Sarag
Koch, Lisa
Jalikis, Florencia
Yeh, Matthew M.
MODERN PATHOLOGY, 2017, 30 : 414A - 414A
[34] The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
Jasirwan, Chyntia Olivia Maurine
Lesmana, Cosmas Rinaldi Adithya
Hasan, Irsan
Sulaiman, Andri Sanityosos
Gani, Rino Alvani
BIOSCIENCE OF MICROBIOTA FOOD AND HEALTH, 2019, 38 (03): : 81 - 88
[35] The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
Mai, Huanzhuo
Yang, Xing
Xie, Yulan
Zhou, Jie
Wang, Qing
Wei, Yiru
Yang, Yuecong
Lu, Dongjia
Ye, Li
Cui, Ping
Liang, Hao
Huang, Jiegang
FRONTIERS IN MICROBIOLOGY, 2024, 14
[36] Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
Wang, Tianjiao
Guo, Xue-Kun
Xu, Huji
FRONTIERS IN MICROBIOLOGY, 2021, 12
[37] Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
Alisi, Anna
Ceccarelli, Sara
Panera, Nadia
Nobili, Valerio
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2012, 2 : 1 - 4
[38] Non-alcoholic fatty liver disease severity and gut microbiota in type 2 diabetes patients
Dai, C. Y.
Tsai, Y. C.
Hung, W. W.
Hung, W. C.
Chang, C. C.
Tsai, H. J.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 94 - 94
[39] Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients
Tsai, Hui-Ju
Tsai, Yi-Chun
Hung, Wei-Wen
Hung, Wei-Chun
Chang, Chen-Chia
Dai, Chia-Yen
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (03):
[40] The Increased Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients is not Related To Inflammatory Load
Erzin, Y.
Demir, N.
Cabuk, C.
Kantarci, F.
Hatemi, I.
Celik, A. F.
JOURNAL OF CROHNS & COLITIS, 2015, 9 : S363 - S363

← 1 2 3 4 5 →